Effects of Transcranial Magnetic Stimulation on Visual Outcome in Patients After Cataract Surgery

Shanghai High Myopia Study Group1 site in 1 country200 target enrollmentOctober 2024

ConditionsCataract Surgery Experience

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cataract Surgery Experience
Sponsor: Shanghai High Myopia Study Group
Enrollment: 200
Locations: 1
Primary Endpoint: Visual acuity
Status: Not yet recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients after cataract surgery. The main question it aims to answer is:

• Does TMS improve the visual outcome in patients after cataract surgery? Researchers will compare TMS to the sham-controlled treatment (exposure to recorded sounds of pulses without real magnetic stimulation) to see if TMS works to improve the visual outcomes of patients after cataract surgery.

Participants will

Undergo TMS treatment or a sham-controlled treatment for consecutive 5 days.
Visit the clinic once every 2 weeks for checkups and tests.

Registry

clinicaltrials.gov

Start Date

October 2024

End Date

October 2026

Last Updated

last year

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Shanghai High Myopia Study Group

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Post cataract surgery
•Best-corrected visual acuity less than 0.1logMAR

Exclusion Criteria

•Diagnosed with cognitive impairment or mental disorders and unable to cooperate with treatment;
•Diagnosed with significant opacity of refractive media that affects observation of visual function;
•History of epileptic seizures;
•Long term use of psychotropic drugs；
•Metal implants in the body.